**Core Concept**
Buprenorphine is a mixed opioid agonist-antagonist used for the treatment of opioid use disorder and chronic pain management. It acts on the mu-opioid receptors in the brain, producing analgesia and euphoria, but with a ceiling effect that limits its potential for overdose and dependence.

**Why the Correct Answer is Right**
Buprenorphine's unique pharmacological profile allows it to activate mu-opioid receptors, but with a lower efficacy compared to full agonists like morphine. This partial agonism is responsible for its ceiling effect, which reduces the risk of respiratory depression and overdose. Additionally, buprenorphine has a high affinity for kappa-opioid receptors, which contributes to its analgesic and anti-withdrawal effects.

**Why Each Wrong Option is Incorrect**
**Option A:**
Buprenorphine is not a pure antagonist, as it still produces some degree of opioid effect.
**Option B:**
Buprenorphine is not a full agonist, as it does not produce the same level of opioid effect as morphine or fentanyl.
**Option C:**
Buprenorphine is not a non-opioid analgesic, as its mechanism of action involves opioid receptors.

**Clinical Pearl / High-Yield Fact**
Buprenorphine's ceiling effect makes it a safer option for patients with a history of opioid use disorder, as it reduces the risk of overdose and dependence.

**Correct Answer: C. Buprenorphine is a mixed opioid agonist-antagonist.**